| 1. Tanaka Y, Niwa S, Nishioka H, Yamanaka T, Torizuka M, Yoshinaga K, Kobayashi N, Ikeda Y, Arai H.. (1994) New potent prolyl endopeptidase inhibitors: synthesis and structure-activity relationships of indan and tetralin derivatives and their analogues., 37 (13): [PMID:8027988] [10.1021/jm00039a019] |
| 2. Portevin B, Benoist A, Rémond G, Hervé Y, Vincent M, Lepagnol J, De Nanteuil G.. (1996) New prolyl endopeptidase inhibitors: in vitro and in vivo activities of azabicyclo[2.2.2]octane, azabicyclo[2.2.1]heptane, and perhydroindole derivatives., 39 (12): [PMID:8691432] [10.1021/jm950858c] |
| 3. Wallén EA, Christiaans JA, Forsberg MM, Venäläinen JI, Männistö PT, Gynther J.. (2002) Dicarboxylic acid bis(L-prolyl-pyrrolidine) amides as prolyl oligopeptidase inhibitors., 45 (20): [PMID:12238937] [10.1021/jm020966g] |
| 4. Jarho EM, Wallén EA, Christiaans JA, Forsberg MM, Venäläinen JI, Männistö PT, Gynther J, Poso A.. (2005) Dicarboxylic acid azacycle l-prolyl-pyrrolidine amides as prolyl oligopeptidase inhibitors and three-dimensional quantitative structure-activity relationship of the enzyme-inhibitor interactions., 48 (15): [PMID:16033257] [10.1021/jm0500020] |
| 5. Ahmad VU, Hussain H, Jassbi AR, Hussain J, Bukhari IA, Yasin A, Aziz N, Choudhary MI.. (2003) New bioactive diterpene polyesters from Euphorbia decipiens., 66 (9): [PMID:14510601] [10.1021/np020186a] |
| 6. Song KS, Raskin I.. (2002) A prolyl endopeptidase-inhibiting benzofuran dimer from Polyozellus multiflex., 65 (1): [PMID:11809072] [10.1021/np010194b] |
| 7. Lawandi J, Gerber-Lemaire S, Juillerat-Jeanneret L, Moitessier N.. (2010) Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors., 53 (9): [PMID:20058865] [10.1021/jm901104g] |
| 8. Racys DT, Rea D, Fülöp V, Wills M.. (2010) Inhibition of prolyl oligopeptidase with a synthetic unnatural dipeptide., 18 (13): [PMID:20627594] [10.1016/j.bmc.2010.05.012] |
| 9. PubChem BioAssay data set, |
| 10. Mariaule G, De Cesco S, Airaghi F, Kurian J, Schiavini P, Rocheleau S, Huskić I, Auclair K, Mittermaier A, Moitessier N.. (2016) 3-Oxo-hexahydro-1H-isoindole-4-carboxylic Acid as a Drug Chiral Bicyclic Scaffold: Structure-Based Design and Preparation of Conformationally Constrained Covalent and Noncovalent Prolyl Oligopeptidase Inhibitors., 59 (9): [PMID:26619267] [10.1021/acs.jmedchem.5b01296] |
| 11. Hostalkova A, Marikova J, Opletal L, Korabecny J, Hulcova D, Kunes J, Novakova L, Perez DI, Jun D, Kucera T, Andrisano V, Siatka T, Cahlikova L.. (2019) Isoquinoline Alkaloids from Berberis vulgaris as Potential Lead Compounds for the Treatment of Alzheimer's Disease., 82 (2): [PMID:30701972] [10.1021/acs.jnatprod.8b00592] |
| 12. Plescia J, De Cesco S, Patrascu MB, Kurian J, Di Trani J, Dufresne C, Wahba AS, Janmamode N, Mittermaier AK, Moitessier N.. (2019) Integrated Synthetic, Biophysical, and Computational Investigations of Covalent Inhibitors of Prolyl Oligopeptidase and Fibroblast Activation Protein α., 62 (17): [PMID:31393718] [10.1021/acs.jmedchem.9b00642] |
| 13. Plescia J, Hédou D, Pousse ME, Labarre A, Dufresne C, Mittermaier A, Moitessier N.. (2022) Modulating the selectivity of inhibitors for prolyl oligopeptidase inhibitors and fibroblast activation protein-α for different indications., 240 [PMID:35797897] [10.1016/j.ejmech.2022.114543] |
